Immuno-oncology is a promising therapeutic approach that harnesses the patient’s own immune system to help fight cancer. Our strategy is to develop novel combinations that target each of the escape mechanisms used by tumor cells to evade the immune system. Our immuno-oncology pipeline contains molecules that enhance immune response, tumor destruction or immune cell memory and compounds that target the tumor micro-environment.